The western blot, electrophoretic mobility shift assay, chromatin immunoprecipitation assay, enzyme-linked immunosorbent assay and cytokinesis-block micronucleus were applied in this study.
It was shown that TCS inhibited the HSV-1-induced NF-¦ÊB activation. Meanwhile, in HSV-1 infected cells, TCS treatment activated significantly more p53 and BAX, with no DNA damage and less S phase arrest compared with uninfected cells. The activation of BAX in infected cells correlated with the cell death signaling of p53.
Taken together, these results suggest that the anti-HSV-1 effect of TCS is related to its suppression of NF-¦ÊB activation and regulation of p53-dependent cell death in infected cells.